HTGM - HTG Molecular Q2 GAAP loss per share widens revenue down August, 11 2022 04:11 PM HTG Molecular Diagnostics Inc. HTG Molecular press release ( NASDAQ: HTGM ): Q2 GAAP EPS of -$0.54 (vs. -$0.39 Y/Y). Revenue of $1.5M (-28.6% Y/Y). For further details see: HTG Molecular Q2 GAAP loss per share widens, revenue down